Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-P Droz

Showing results (81-90 of 364) with videos related to

Pageof 37
Sort By:
Critical Reviews in Oncology/Hematology|April 1, 1996
Chemotherapy in adult germ cell tumorsS Culine, A Kramar, P Biron, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Salvage chemotherapy in non-dysgerminomatous germ cell tumours of the ovaryS Culine, C Lhomme, F Farhat, et al.
In Vivo (Athens, Greece)|January 1, 1994
Experimental animal models for the study of therapeutic approaches in renal cell carcinomaG G Hillman, J P Droz, G P Haas
Cancer Chemotherapy and Pharmacology|January 1, 1982
Some effects of chemotherapeutic drugs. III. Short- and long-term effects of cis-platinum on various hematopoietic compartments and on the kidney of the mouseD Dumenil, D Droz, J P Droz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Treatment of good-risk disseminated non-seminomatous germ cell tumours: the less bleomycin, the more cisplatin?S Culine, M Mahjoubi, I Philippot, et al.
European Urology|August 9, 2005
Pattern of relapse after first line treatment of advanced stage germ-cell tumorsA Fléchon, S Culine, C Théodore, et al.
La Nouvelle Presse Medicale|April 30, 1977
[Reflexions on early chemotherapy and complementary immunotherapy for treatment of solid tumors]J L Amiel, J P Droz, J P Pilleron
Urology|March 29, 2006
Malignant teratoma 32 years after treatment of germ cell tumor confined to testisM Pavic, P Meeus, I Treilleux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1996
High-dose chemotherapy in germ-cell tumorsJ P Droz, S Culine, P Biron, et al.
Cancer Investigation|January 1, 1995
Phase II trial of ifosfamide, fluorouracil, and folinic acid (FIFO regimen) in relapsed and refractory urothelial cancerJ Kattan, S Culine, C Theodore, et al.
Pageof 37

Showing results (81-90 of 364) with videos related to

Sort By:
Pageof 37
Critical Reviews in Oncology/Hematology|April 1, 1996
Chemotherapy in adult germ cell tumorsS Culine, A Kramar, P Biron, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Salvage chemotherapy in non-dysgerminomatous germ cell tumours of the ovaryS Culine, C Lhomme, F Farhat, et al.
In Vivo (Athens, Greece)|January 1, 1994
Experimental animal models for the study of therapeutic approaches in renal cell carcinomaG G Hillman, J P Droz, G P Haas
Cancer Chemotherapy and Pharmacology|January 1, 1982
Some effects of chemotherapeutic drugs. III. Short- and long-term effects of cis-platinum on various hematopoietic compartments and on the kidney of the mouseD Dumenil, D Droz, J P Droz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Treatment of good-risk disseminated non-seminomatous germ cell tumours: the less bleomycin, the more cisplatin?S Culine, M Mahjoubi, I Philippot, et al.
European Urology|August 9, 2005
Pattern of relapse after first line treatment of advanced stage germ-cell tumorsA Fléchon, S Culine, C Théodore, et al.
La Nouvelle Presse Medicale|April 30, 1977
[Reflexions on early chemotherapy and complementary immunotherapy for treatment of solid tumors]J L Amiel, J P Droz, J P Pilleron
Urology|March 29, 2006
Malignant teratoma 32 years after treatment of germ cell tumor confined to testisM Pavic, P Meeus, I Treilleux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1996
High-dose chemotherapy in germ-cell tumorsJ P Droz, S Culine, P Biron, et al.
Cancer Investigation|January 1, 1995
Phase II trial of ifosfamide, fluorouracil, and folinic acid (FIFO regimen) in relapsed and refractory urothelial cancerJ Kattan, S Culine, C Theodore, et al.
Pageof 37